China has reported 460 human infections with the H7N9 avian flu virus since last October, more than in any year since the novel virus emerged there in 2013, the Centers for Disease Control and Prevention announced last week. During the prior years, 88% of patients developed pneumonia, 68% were admitted to an intensive care unit and 41% died. H7N9 viruses have not been detected in people or birds in the United States and currently pose low risk to public health, CDC said. However, the agency is using reverse genetics to prepare a candidate vaccine virus and will continue to track the virus’ potential for pandemic risk. For more on the H7N9 virus, including guidance for U.S. clinicians, visit www.cdc.gov

Related News Articles

Headline
The World Health Organization Aug. 14 declared a global health emergency due to the recent mpox outbreak in Africa, the second mpox declaration in two years.…
Headline
In the latest "Safety Speaks" conversation, Christi Barney, R.N., vice president of quality and patient safety at Emerson Health, discusses the health system’s…
Headline
In a new blog, Chris DeRienzo, M.D., AHA’s senior vice president and chief physician executive, highlights three ways this year's AHA Leadership Summit…
Headline
The Centers for Disease Control and Prevention has updated respiratory syncytial virus vaccination recommendations for adults 60 and older. Adults aged 60-74…
Blog
From plenaries to interactive sessions to podcasts, the AHA’s Patient Safety Initiative had a huge presence at last month’s AHA Leadership Summit. Over three…
Chairperson's File
Today’s health care workforce uses an amazing array of creative approaches, strategies and technology tools to ensure every patient receives quality care.At…